Evidence map›Paper›PMID 41888432›Full record

ArticleCommunications biology2026

Modulating microbial intake helps to maintain the gut microbiome diversity.

Vitor M Marquioni, Ann-Cathrin Hofacker, Jocksan V Villavicencio, Florence Bansept

Abstract read
In one paragraph

Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Vitor M MarquioniLaboratoire de Chimie Bactérienne (UMR7283), Turing Centre for Living Systems, IMM, IM2B, CNRS, Aix Marseille Université, Marseille, France. vitor.marquioni-monteiro@univ-amu.fr.ORCID http://orcid.org/0000-0002-8904-0230
Ann-Cathrin HofackerMax Planck Institute for Evolutionary Biology, Plön, Germany.
Jocksan V VillavicencioLaboratoire de Chimie Bactérienne (UMR7283), Turing Centre for Living Systems, IMM, IM2B, CNRS, Aix Marseille Université, Marseille, France.
Florence BanseptLaboratoire de Chimie Bactérienne (UMR7283), Turing Centre for Living Systems, IMM, IM2B, CNRS, Aix Marseille Université, Marseille, France. fbansept@imm.cnrs.fr.ORCID http://orcid.org/0000-0003-0562-9222

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The animal gut is home to a myriad of microbes whose diversity has a proven impact on the host's health. Indeed, lower values of this metric often correlate with pathological status. In this context, processes involved in the gut microbiome assembly have been studied in the search for optimal nutritional habits and medical interventions. While the nutritional content of food has been extensively investigated, its microbial content has comparatively received little attention as an ecological driver of the gut microbiome. Furthermore, while probiotics use is increasing, the question of optimal dose remains open. Here, we fill these gaps by designing a model that tracks the effect of microbial migration bursts - that result from feeding and/or from probiotics administration - on the gut community alpha-diversity. We find that there is a set of feeding parameters (feeding interval and food microbial content) that maximizes the gut Shannon alpha-diversity, which we call the Maximal Diversity Strategy (MDS). Using a combination of numerical and analytical techniques, we show that for large numbers of microbial types, in the diversity maximization scenario, diversity converges to that of the food, and the feeding rate converges to the average clearance rate. These results remain robust both to the choice of distribution for the parameters that describe microbial dynamics and to weak dispersal noise, thus increasing their theoretical significance and potential for empirical exploration. We believe this work can help evaluate how quantitative ecological control can be used to improve the intake protocols of live biotherapeutic products.

Indexed as

Gastrointestinal MicrobiomeProbioticsAnimalsBacteriaBiodiversityModels, Biological

Identifiers

PMID41888432
PMCPMC13083979

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.